Yingxi Lin.

Yingxi Li

Professor of psychiatry and neuroscience
University of Texas Southwestern Medical Center

Yingxi Li is professor of psychiatry and neuroscience, and chief of the Psychiatry Neuroscience Research Division at University of Texas Southwestern Medical Center. Her research focuses on uncovering molecular and circuit mechanisms in neurodevelopment, memory formation and neuropsychiatric conditions. Employing a broad array of multidisciplinary experimental techniques, work in her lab spans analyses from the genomic and molecular level to synapse, circuit and whole-animal behavioral levels.

Originally from China, Lin studied engineering physics at Tsinghua University and received her Ph.D. in biophysics from Harvard University. She conducted her postdoctoral research under Michael Greenberg at Harvard Medical School. She was assistant professor from 2009 to 2015 and associate professor from 2015 to 2018 at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology. Prior to her current role, she was full professor and director of the Neuroscience Graduate Program at SUNY Upstate Medical University.

Explore more from The Transmitter

Headshots of Yale researchers Yong-Hui Jiang and Jiangbing Zhou.

Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions

Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.

By Natalia Mesa
3 June 2026 | 11 min read

What counts as a ‘naturalistic’ behavior?

Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.

By Paul Middlebrooks
3 June 2026 | 1 min read
Research image of brain cells involved with Amyotrophic lateral sclerosis (ALS) illuminated through genetic tools

Allen Institute sets sights on treatments for five brain diseases

The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.

By Calli McMurray
2 June 2026 | 5 min read